If you liked this article you might like

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season
EQT Midstream Partners, AbbVie, Blackstone Group: 'Mad Money' Lightning Round
Here's Why You Should Hope for Panic: Cramer's 'Mad Money' Recap (Friday 4/21/17)
Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector